Type
. The legacy of Armauer Hansen. Archives of pathology & laboratory medicine [Internet]. 2000;124(4):496-7. Available from: http://www.archivesofpathology.org/doi/pdf/10.1043/0003-9985%282000%29124%3C0496%3ATLOAH%3E2.0.CO%3B2
Type
. Albert S. Ashmead and the First International Leprosy Conference, Berlin, 1897. Transactions & studies of the College of Physicians of Philadelphia. 1999;21:52-4.
Type
. Immunological cytokine correlates of protective immunity and pathogenesis in leprosy. Scandinavian journal of immunology. 2000;51(4):419-28.
Type
. [Leprosy and sexuality: living with a difference]. Revista latino-americana de enfermagem [Internet]. 1999;7(1):85-91. Available from: http://www.scielo.br/pdf/rlae/v7n1/13452.pdf
Type
. Interleukin-12 amplifies the M. leprae hsp65-cytotoxic response in the presence of tumour necrosis factor-alpha and interferon-gamma generating CD56+ effector cells: interleukin-4 downregulates this effect. Scandinavian journal of immunology. 2000;51(3):262-70.
Type
Proceedings of the Workshop on the Prevention of Leprosy. Pohnpei, Federated States of Micronesia. 25-27 May 1999. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association [Internet]. 1999;67(4 Suppl):S1-82. Available from: http://ila.ilsl.br/pdfs/v67n4s1a01.pdf
Type
. Immunotherapy with Mycobacterium vaccae in the treatment of mycobacterial disease. The Journal of infection. 1999;39(3):179-82.
Type
. Detection of disease related immune complexes in the serum of leprosy patients. A novel single step method. Journal of neuroimmunology. 2000;105(1):64-8.
Type
. [Neuropathy of leprosy: characteristics of cases in 1962-1995]. Revista de neurologia. 1999;28(3):232-6.
Type
. Metabolism of thalidomide in human microsomes, cloned human cytochrome P-450 isozymes, and Hansen's disease patients. Journal of biochemical and molecular toxicology. 2000;14(3):140-7.